ctrl K

AI Score

Unlock

LENZ Therapeutics Inc. (LENZ)

AI Score

Unlock

21.65

0.11 (0.51%)

At close: Mar 04, 2025, 9:54 AM

LENZ Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	15M	n/a	n/a	n/a
Cost of Revenue	2.41M	8.35M	734K	121K	n/a
Gross Profit	-2.41M	6.65M	-734K	-121K	n/a
Operating Income	-73.11M	-105.64M	-60.44M	-13.5M	-29K
Interest Income	10.95M	n/a	n/a	n/a	n/a
Pretax Income	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Net Income	-124.65M	-101.05M	-70.76M	-68.37M	-109K
Selling & General & Admin	40.97M	32.85M	21.78M	4.26M	29K
Research & Development	29.73M	64.44M	37.93M	9.12M	n/a
Other Expenses	n/a	19K	-869K	n/a	n/a
Operating Expenses	70.7M	97.29M	59.71M	13.38M	29K
Interest Expense	n/a	n/a	n/a	40K	80K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	73.11M	105.64M	60.44M	13.5M	29K
Income Tax	-124.65M	347K	497.44K	n/a	-171.86K
Shares Outstanding (Basic)	8.15M	7.84M	8.29M	8.3M	8.3M
Shares Outstanding (Diluted)	8.15M	7.84M	8.29M	8.3M	8.3M
EPS (Basic)	-15.3	-12.89	-8.54	-8.24	-0.01
EPS (Diluted)	-15.3	-12.89	-8.54	-8.24	-0.01
EBITDA	-122.24M	-97.29M	-70.03M	-68.21M	-29K
Depreciation & Amortization	2.41M	8.35M	734K	121K	171.86K